Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART

被引：0

作者：

Potena, L. ^{[1
]}

Barberini, F. ^{[1
]}

Boffini, M. ^{[2
]}

Amarelli, C. ^{[3
]}

Pellegrini, C. ^{[4
]}

Livi, U. ^{[5
]}

Masciocco, G. ^{[6
]}

Faggian, G. ^{[7
]}

Gerosa, G. ^{[8
]}

Lilla, P. ^{[9
]}

Marraudino, N. ^{[10
]}

Porcu, M. ^{[11
]}

Guarisco, R. ^{[12
]}

Maccherini, M. ^{[13
]}

机构：

[1] AO S Orsola Malpighi, Bologna, Italy

[2] ASO Molinette S Giovanni Battista, Turin, Italy

[3] Osped Monaldi, Naples, Italy

[4] Policlin San Matteo, I-27100 Pavia, Italy

[5] AOU S Maria Misericordia, Udine, Italy

[6] AO Niguarda Ca Granda, Milan, Italy

[7] Osped Civile, I-37126 Verona, Italy

[8] AOU Padova, Padua, Italy

[9] AO San Camillo Forlanini, Rome, Italy

[10] Policlin Bari, Bari, Italy

[11] AO G Brotzu, Cagliari, Italy

[12] Novartis Farma, Origgio, VA, Italy

[13] AOU Senese, Siena, Italy

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期

关键词：

D O I：

10.1016/j.healun.2013.01.303

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

352

引用

页码：S136 / S136

页数：1

共 50 条

[1] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART.
Potena, L.
Barberini, F.
Boffini, M.
Maiello, C.
Pedrazzini, G.
Faggian, G.
Gerosa, G.
Lilla, P.
Marraudino, N.
Corda, M.
Bernazzali, S.
Guarisco, R.
Livi, U.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 93 - 93
[2] Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART
Potena, Luciano
Pellegrini, Carlo
Grigioni, Francesco
Amarelli, Cristiano
Livi, Ugolino
Maccherini, Massimo
Masciocco, Gabriella
Faggian, Giuseppe
della Monica, Paola Lilla
Gerosa, Gino
Marraudino, Nicola
Gorda, Marco
Boffini, Massimo
TRANSPLANTATION, 2018, 102 (03) : 493 - 501
[3] Early vs. Delayed EVERolimus in De Novo HEART Transplant Recipients
Potena, L.
Rinaldi, M.
Maiello, C.
Livi, U.
Gerosa, G.
Faggian, G.
Pellegrini, C.
Musumeci, F.
Frigerio, M.
Marraudino, N.
Porcu, M.
Veneziano, A.
Maccherini, M.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S35 - S35
[4] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
Hill, James A.
Hummel, Manfred
Starling, Randall C.
Kobashigawa, Jon A.
Perrone, Sergio V.
Arizon, Jose M.
Simonsen, Svein
Abeywickrama, Kamal H.
Bara, Christoph
TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
[5] Everolimus Immunosuppression in De Novo Heart Transplant Recipients: Clinical and Intravascular Ultrasound Study
Choi, H.
Hong, J.
Kim, M.
Lee, S.
Kim, J.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S280 - S280
[6] CARDIOVASCULAR EVENTS WITH DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS
Potena, Luciano
Schulz, Uwe
Bara, Christoph
Arizon Del Prado, Jose M.
Balfour, Alison
Kohler, Sven
Lopez, Patricia M.
Epailly, Eric
TRANSPLANT INTERNATIONAL, 2013, 26 : 46 - 46
[7] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
Prokopenko, E. I.
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
[8] Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
Lehmkuhl, H.
Hirt, S.
Rinaldi, M.
Bara, C.
Zuckermann, A.
Lopez, P.
Cines, M.
Dong, G.
Keogh, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 74 - 75
[9] 24 month safety results of a randomized, multicenter, double-blind study of everolimus vs azathioprine in de novo heart transplant recipients.
Eisen, H
Kobashigawa, J
Starling, RC
Cretin, N
Jaffe, J
Murphy, J
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 282 - 283
[10] IMPACT OF EVEROLIMUS ON PERICARDIAL AND PLEURAL EFFUSIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS
Barten, M.
Zuckermann, A.
Arizon, J. M.
Dong, G.
Eisen, H.
Kobashigawa, J.
Lehmkuhl, H. B.
Pellegrini, C.
Ross, H.
TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8

← 1 2 3 4 5 →